Resistance training prescription for muscle strength and hypertrophy in healthy adults : a systematic review and Bayesian network meta-analysis

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

OBJECTIVE: To determine how distinct combinations of resistance training prescription (RTx) variables (load, sets and frequency) affect muscle strength and hypertrophy.

DATA SOURCES: MEDLINE, Embase, Emcare, SPORTDiscus, CINAHL, and Web of Science were searched until February 2022.

ELIGIBILITY CRITERIA: Randomised trials that included healthy adults, compared at least 2 predefined conditions (non-exercise control (CTRL) and 12 RTx, differentiated by load, sets and/or weekly frequency), and reported muscle strength and/or hypertrophy were included.

ANALYSES: Systematic review and Bayesian network meta-analysis methodology was used to compare RTxs and CTRL. Surface under the cumulative ranking curve values were used to rank conditions. Confidence was assessed with threshold analysis.

RESULTS: The strength network included 178 studies (n=5097; women=45%). The hypertrophy network included 119 studies (n=3364; women=47%). All RTxs were superior to CTRL for muscle strength and hypertrophy. Higher-load (>80% of single repetition maximum) prescriptions maximised strength gains, and all prescriptions comparably promoted muscle hypertrophy. While the calculated effects of many prescriptions were similar, higher-load, multiset, thrice-weekly training (standardised mean difference (95% credible interval); 1.60 (1.38 to 1.82) vs CTRL) was the highest-ranked RTx for strength, and higher-load, multiset, twice-weekly training (0.66 (0.47 to 0.85) vs CTRL) was the highest-ranked RTx for hypertrophy. Threshold analysis demonstrated these results were extremely robust.

CONCLUSION: All RTx promoted strength and hypertrophy compared with no exercise. The highest-ranked prescriptions for strength involved higher loads, whereas the highest-ranked prescriptions for hypertrophy included multiple sets.

PROSPERO REGISTRATION NUMBER: CRD42021259663 and CRD42021258902.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:57

Enthalten in:

British journal of sports medicine - 57(2023), 18 vom: 05. Sept., Seite 1211-1220

Sprache:

Englisch

Beteiligte Personen:

Currier, Brad S [VerfasserIn]
Mcleod, Jonathan C [VerfasserIn]
Banfield, Laura [VerfasserIn]
Beyene, Joseph [VerfasserIn]
Welton, Nicky J [VerfasserIn]
D'Souza, Alysha C [VerfasserIn]
Keogh, Joshua A J [VerfasserIn]
Lin, Lydia [VerfasserIn]
Coletta, Giulia [VerfasserIn]
Yang, Antony [VerfasserIn]
Colenso-Semple, Lauren [VerfasserIn]
Lau, Kyle J [VerfasserIn]
Verboom, Alexandria [VerfasserIn]
Phillips, Stuart M [VerfasserIn]

Links:

Volltext

Themen:

Aging
Journal Article
Meta-Analysis
Muscle
Muscle, skeletal
Systematic Review
Weight lifting

Anmerkungen:

Date Completed 02.10.2023

Date Revised 21.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1136/bjsports-2023-106807

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359155693